83.53 USD
-0.44 (-0.52%)
Overall PVLA gets a fundamental rating of 3 out of 10. We evaluated PVLA against 525 industry peers in the Biotechnology industry. The financial health of PVLA is average, but there are quite some concerns on its profitability. PVLA is valied quite expensively at the moment, while it does show a decent growth rate.
1. Profitability
1.1 Basic Checks
- PVLA had negative earnings in the past year.
- In the past year PVLA has reported a negative cash flow from operations.
- PVLA had negative earnings in each of the past 5 years.
- In the past 5 years PVLA always reported negative operating cash flow.
1.2 Ratios
- PVLA's Return On Assets of -51.84% is in line compared to the rest of the industry. PVLA outperforms 48.57% of its industry peers.
- PVLA has a Return On Equity of -89.05%. This is comparable to the rest of the industry: PVLA outperforms 49.14% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -51.84% | ||
| ROE | -89.05% | ||
| ROIC | N/A |
ROA(3y)-39.21%
ROA(5y)-36.57%
ROE(3y)-79.28%
ROE(5y)-89.59%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- The Profit Margin and Operating Margin and Gross Margin are not available for PVLA so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | N/A |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
2. Health
2.1 Basic Checks
- PVLA does not have a ROIC to compare to the WACC, probably because it is not profitable.
- Compared to 1 year ago, PVLA has more shares outstanding
- Compared to 5 years ago, PVLA has more shares outstanding
- Compared to 1 year ago, PVLA has a worse debt to assets ratio.
2.2 Solvency
- PVLA has an Altman-Z score of 18.35. This indicates that PVLA is financially healthy and has little risk of bankruptcy at the moment.
- The Altman-Z score of PVLA (18.35) is better than 88.38% of its industry peers.
- PVLA has a Debt/Equity ratio of 0.41. This is a healthy value indicating a solid balance between debt and equity.
- PVLA has a worse Debt to Equity ratio (0.41) than 69.90% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.41 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 18.35 |
ROIC/WACCN/A
WACC8.86%
2.3 Liquidity
- A Current Ratio of 6.70 indicates that PVLA has no problem at all paying its short term obligations.
- Looking at the Current ratio, with a value of 6.70, PVLA is in the better half of the industry, outperforming 68.38% of the companies in the same industry.
- PVLA has a Quick Ratio of 6.70. This indicates that PVLA is financially healthy and has no problem in meeting its short term obligations.
- Looking at the Quick ratio, with a value of 6.70, PVLA is in the better half of the industry, outperforming 68.57% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 6.7 | ||
| Quick Ratio | 6.7 |
3. Growth
3.1 Past
- PVLA shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 73.54%, which is quite impressive.
- Looking at the last year, PVLA shows a very negative growth in Revenue. The Revenue has decreased by -100.00% in the last year.
EPS 1Y (TTM)73.54%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%74.62%
Revenue 1Y (TTM)-100%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
3.2 Future
- PVLA is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 29.91% yearly.
- PVLA is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 607.13% yearly.
EPS Next Y-17.14%
EPS Next 2Y-14.82%
EPS Next 3Y-22.99%
EPS Next 5Y29.91%
Revenue Next Year-100%
Revenue Next 2Y39.36%
Revenue Next 3Y871.72%
Revenue Next 5Y607.13%
3.3 Evolution
4. Valuation
4.1 Price/Earnings Ratio
- PVLA reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
- Also next year PVLA is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
- PVLA's earnings are expected to decrease with -22.99% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-14.82%
EPS Next 3Y-22.99%
5. Dividend
5.1 Amount
- No dividends for PVLA!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
PALVELLA THERAPEUTICS INC / PVLA FAQ
What is the ChartMill fundamental rating of PALVELLA THERAPEUTICS INC (PVLA) stock?
ChartMill assigns a fundamental rating of 3 / 10 to PVLA.
What is the valuation status for PVLA stock?
ChartMill assigns a valuation rating of 0 / 10 to PALVELLA THERAPEUTICS INC (PVLA). This can be considered as Overvalued.
How profitable is PALVELLA THERAPEUTICS INC (PVLA) stock?
PALVELLA THERAPEUTICS INC (PVLA) has a profitability rating of 1 / 10.